Stellate Ganglion Block for the Management of Cannabis Use Disorder: A Case Series
Abstract Currently, there are no approved or consistently effective pharmacological treatments for managing cannabis use disorder. Three patients diagnosed with…
cannabis withdrawal syndrome subtypes
Clinical management of cannabis withdrawal
Abstract Background and Aims: Cannabis withdrawal is a well‐characterized phenomenon that occurs in approximately half of regular and dependent cannabis…
Cannabis dabbing
Abstract Cannabis dabbing refers to the recreational inhalation of extremely concentrated tetrahydrocannabinol, the main psychotropic cannabinoid derived from the marijuana…
Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?
Abstract Background: For cannabis-dependent subjects, the relationship between cannabis withdrawal syndrome (CWS) severity and the urine cannabinoid concentrations are unclear;…